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Abstract
Using the Vollmer/Orbach transformation protocol, transformation frequencies of a pyr-4 (OMP
decarboxylase) strain of Neurospora crassa of circa 10(3)/µg are routinely achievable. At these levels of
transformation, it is feasible to screen out ectopic integrations and look specifically for homologous
integration events. Homologous integrants were sought by transforming a pyr-4 recipient with interrupted
or incomplete copies of the cloned pyr-4 gene derived from the pyr+ clone in plasmid pFB6, selecting by
complementation of the pyrimidine auxotrophy in the recipient
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Transformation of Neurospora pyr-4 with defective donor genes
A. Radford and J.A. Glazebrook - Department of Genetics, University of Leeds, Leeds, LS2 9JT,
U.K.
Using the Vollmer/Orbach transformation protocol, transformation frequencies of a pyr-4 (OMP
decarboxylase) strain of Neurospora crassa of circa 10(3)/µg are routinely achievable. At these
levels of transformation, it is feasible to screen out ectopic integrations and look specifically for
homologous integration events. Homologous integrants were sought by transforming a pyr-4
recipient with interrupted or incomplete copies of the cloned pyr-4 gene derived from the pyr+
clone in plasmid pFB6, selecting by complementation of the pyrimidine auxotrophy in the
recipient.
Defective clones used as donors were of two types: 1) Clones inactivated by the insertion of the
transposon Tn1000 into the pyr-4 gene, the method of construction employing the F-mediated
transfer of the pyr-4+, ampR plasmid by conjugation into a pyr-4-, ampR recipient, and
identifying pyr-4-, ampR exconjugants. 2) Inactivating pyr-4+ clones by cutting with BamH1
within the distal portion of the coding region and making a translational fusion with lacZ, this
construct having ß-galactosidase but not OMP decarboxylase activity.
Using two strains inactivated by Tn1000 ( gd5 and gd7) and one pyr- 4/lacZ fusion as donor
DNA, transformation of a pyr-4 recipient was carried out. Pyrimidine-independent transformants
were obtained at low frequency with each of the donor clones (see table). Control reversion
frequency was circa 5 x 10(-8). With the three defective donors, restoration of an intact and
functional pyr-4 gene requires integration at the homologous chromosomal locus, with a
homologous recombination event between the site of the mutant lesion in the recipient and the
transposon integration site or the fusion site in the donor. This was confirmed by Southern
analysis.
Transformation of pyr-4
plasmid
pFB6
gd5
gd7
pyr-4/lacZ
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pyr+
pyrpyrpyr-

DNA
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5
10
10
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8.6
17.5
17.5
11.5
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µg
µg
µg

kb
kb
kb
kb

transfo.
per µg
900
1.1
0.9
1.9

transfo. per
spheroplast
2380
6
5
11

x
x
x
x

10(-7)
10(-7)
10(-7)
10(-7)

The locations of the three donor lesions are shown in the figure, based on restriction mapping.
The lesion in the recipient is clearly proximal to the fusion site with lacZ, although its location
within the circa 1.5 kb of the coding region proximal to that site is not yet known.
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The constraints on the site of the required crossover mean that only some of the homologous
integrants will give rise to pyrimidine-independent transformants. However, all such
transformants are truly wild type in growth rate, unlike heterologous transformants.
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